从暗盘“破发”到首日大涨，这只港股新股“逆袭”

Group 1: New Listings in Hong Kong - Three new stocks, Taide Pharmaceutical, Yunzhisheng, and IFBH, officially listed on the Hong Kong stock market on June 30 [2] - In the dark market prior to listing, IFBH saw a significant increase of over 60%, while Yunzhisheng experienced a slight decline of 2.88% and Taide Pharmaceutical rose by 1.80% [2] - On the official listing day, Yunzhisheng surged by 44.59%, reaching a total market capitalization of HKD 21 billion, while IFBH increased by 42.09% to HKD 10.5 billion, and Taide Pharmaceutical rose by 0.65% to HKD 4.4 billion [2] Group 2: Subscription Results - Yunzhisheng's public offering subscription rate was only 91.66 times, significantly lower than IFBH's 2682.35 times and Taide Pharmaceutical's 301.15 times [5] - The international offering subscription rates were also lower for Yunzhisheng at 1.70 times compared to IFBH's 22.93 times and Taide Pharmaceutical's 2.43 times [5] Group 3: Company Profiles - IFBH is a Thailand-based company specializing in ready-to-drink beverages and ready-to-eat foods, leading the coconut water market in mainland China with a projected market share of approximately 34% in 2024 [6][7] - IFBH's gross margin is expected to increase from 34.7% in 2023 to 36.7% in 2024, with net profit margin rising from 19.2% to 21.1% [6] - Yunzhisheng focuses on AI solutions for daily life and medical applications, holding a market share of 0.6% in China's AI solutions market, ranking fourth [7] - Yunzhisheng previously attempted to list on the STAR Market in China but withdrew its application in 2021 to focus on business and technology development [7]